Unclaimed Scholar Profile
Are you Mark Hatherill? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of Cape TownASIDASID-4428-5718-1787 orcid.org/0000-0003-3491-1809
Mark Hatherill
University of Cape Town•South Africa
Faculty researcher at University of Cape Town (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Tuberculosis Research and Epidemiology#Infectious Diseases and Tuberculosis#Immune responses and vaccinations#Diagnosis and treatment of tuberculosis
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 17,419 | 8,361 |
| h-index | 70 | 53 |
| i10-index | 201 | 141 |
Annual Citation Growth
Verified Citations / Year0
2020836
2021+40%1.2k
2022+29%1.5k
2023+33%2.0k
2024-8%1.8k
2025-45%1.0k
2026Scholarship Distribution & Proportions351 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (14,284) • 18% Global Research Impact (3,135)
351 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (351)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Published in The Lancet•2013
DOI: 10.1016/s0140-6736(13)60177-4 Verified Peer-Reviewed
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
DOI: 10.1016/s0140-6736(15)01316-1 Verified Peer-Reviewed
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
Published in New England Journal of Medicine•2018
DOI: 10.1056/nejmoa1714021 Verified Peer-Reviewed
Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
Published in New England Journal of Medicine•2019
DOI: 10.1056/nejmoa1909953 Verified Peer-Reviewed
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Published in New England Journal of Medicine•2014
DOI: 10.1056/nejmoa1314210 Verified Peer-Reviewed
Showing 1 – 5 of 351 publications
1 / 71